Search research articles
Contact Us
Filters
Showing results (931-940 of 1,012) with videos related to
Page
of 102
Sort By:
European Journal of Cancer Care
|
January 19, 2016
The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy
C Miaskowski, B A Cooper, B Aouizerat, et al.
Journal of Internal Medicine
|
February 28, 2019
Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age
T A Eyre, N Martinez-Calle, C Hildyard, et al.
Metabolism: Clinical and Experimental
|
May 22, 2003
A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin
Yun-Ping Zhou, Seamus Sreenan, Chien-Yuan Pan, et al.
Nucleic Acids Research
|
September 20, 2013
Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells
Chun-Fui Lai, Koen D Flach, Xanthippi Alexi, et al.
Blood Advances
|
April 23, 2021
Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP
Toby A Eyre, William Wilson, Amy A Kirkwood, et al.
The British Journal of Dermatology
|
November 6, 2023
Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies
Abhishek Abhishek, Matthew D Stevenson, Georgina Nakafero, et al.
Molecular Cancer Therapeutics
|
August 14, 2021
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer
Nyree Crawford, Katie J Stott, Tamas Sessler, et al.
Diabetes
|
August 28, 2001
Calpains play a role in insulin secretion and action
S K Sreenan, Y P Zhou, K Otani, et al.
British Journal of Haematology
|
January 31, 2020
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice
Elisabeth Schorb, Christopher P Fox, Benjamin Kasenda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 12, 2019
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study
Peter Hillmen, Andy C Rawstron, Kristian Brock, et al.
Page
of 102
Search research articles
Search
Showing results (931-940 of 1,012) with videos related to
Sort By:
Page
of 102
European Journal of Cancer Care
|
January 19, 2016
The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy
C Miaskowski, B A Cooper, B Aouizerat, et al.
Journal of Internal Medicine
|
February 28, 2019
Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age
T A Eyre, N Martinez-Calle, C Hildyard, et al.
Metabolism: Clinical and Experimental
|
May 22, 2003
A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin
Yun-Ping Zhou, Seamus Sreenan, Chien-Yuan Pan, et al.
Nucleic Acids Research
|
September 20, 2013
Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells
Chun-Fui Lai, Koen D Flach, Xanthippi Alexi, et al.
Blood Advances
|
April 23, 2021
Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP
Toby A Eyre, William Wilson, Amy A Kirkwood, et al.
The British Journal of Dermatology
|
November 6, 2023
Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies
Abhishek Abhishek, Matthew D Stevenson, Georgina Nakafero, et al.
Molecular Cancer Therapeutics
|
August 14, 2021
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer
Nyree Crawford, Katie J Stott, Tamas Sessler, et al.
Diabetes
|
August 28, 2001
Calpains play a role in insulin secretion and action
S K Sreenan, Y P Zhou, K Otani, et al.
British Journal of Haematology
|
January 31, 2020
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice
Elisabeth Schorb, Christopher P Fox, Benjamin Kasenda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 12, 2019
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study
Peter Hillmen, Andy C Rawstron, Kristian Brock, et al.
Page
of 102